EMEA-001315-PIP02-16

Key facts

Active substance
Fevipiprant
Therapeutic area
Pneumology-allergology
Decision number
P/0124/2018
PIP number
EMEA-001315-PIP02-16
Pharmaceutical form(s)
  • Tablet
  • Chewable tablet
  • Age-appropriate oral liquid dosage form
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Oral use
Contact for public enquiries
Kyowa Kirin Holdings B.V.

Tel. +44 (0)1896 664000
E-mail: regulatorygroup@kyowakirin.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating